Defining the role of natural killer cells in COVID-19
定义自然杀伤细胞在 COVID-19 中的作用
基本信息
- 批准号:10537429
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-06 至 2025-06-05
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcuteAffectAutomobile DrivingBiological AssayCOVID-19COVID-19 impactCOVID-19 patientCOVID-19 severityCell CommunicationCell physiologyCellsCellular biologyCoculture TechniquesDataDiseaseDown-RegulationFunctional disorderFutureImmuneImmune EvasionImmune responseImmune systemImpairmentKnowledgeLigandsLungMeasuresMediatingMediator of activation proteinNK Cell ActivationNatural Killer CellsPathologicPathologyPatientsPeripheralPhenotypePlayPredispositionReceptor CellResearchRoleSARS-CoV-2 infectionSeveritiesSeverity of illnessSystemTestingTherapeuticVaccinationVirus DiseasesWorkbiosafety level 3 facilitycell killingcell typecohortcytotoxiccytotoxicityexhaustexhaustionexperimental studyinsightmonocytepreventreceptorresponsesevere COVID-19therapeutic developmenttumorvirology
项目摘要
PROJECT SUMMARY
Severe COVID-19 induces strong alterations in the peripheral immune system. Some immune cell types take
on a protective role in this disease, while others contribute to disease pathology. One cell type whose
functional role in COVID-19 is not yet known is the natural killer (NK) cell. I previously demonstrated that NK
cells, which can mediate antiviral activity, are strongly altered by severe COVID-19. I have also generated
preliminary data demonstrating that SARS-CoV-2 modulates the expression of ligands for the NK cell activating
receptor NKG2D and allows infected cells to avoid NK cell killing; however, the mechanisms underlying this
remain unexplored. Moreover, although the NK cells of COVID-19 patients are poor mediators of cytotoxicity
against tumor target cells, the functional responses of NK cells from COVID-19 patients to
SARS-CoV-2-infected cells have not been examined. The proposed research seeks to resolve these critical
gaps in our knowledge of the immune response to SARS-CoV-2 by investigating the mechanisms underlying
the phenotype and function of NK cells in COVID-19. To do this, I will 1) Define the mechanisms by which
SARS-CoV-2 modulates NK cell responses; 2) Characterize the functional responses of NK cells from
COVID-19 patients with a wide range of disease severities against target cells infected with SARS-CoV-2; and
3) Elucidate the role of monocyte-NK cell crosstalk in driving NK cell exhaustion in severe COVID-19. I
hypothesize that the experiments described in my proposal will show that prolonged stimulation of peripheral
NK cells by monocytes contributes to exhaustion in the NK cells of severe COVID-19 patients, driving poor
functional responses against SARS-CoV-2-infected target cells that are exacerbated by immune evasion
mechanisms mediated by SARS-CoV-2. To test this hypothesis, I will utilize NK cells and monocytes from a
large cohort of COVID-19 patients with disease severities ranging from mildly symptomatic to fatal. I will
perform functional assays that test the responses of these NK cells against target cells infected with
replication-competent SARS-CoV-2 in Stanford’s BSL3 facilities. I will also assess the ability of monocytes from
severe COVID-19 patients to induce activation and exhaustion in healthy NK cells by establishing a co-culture
system with these two cell types. Overall, my experiments will uncover the basis for the NK cell phenotype
observed in COVID-19, the effects of this phenotype on NK cell responses to SARS-CoV-2-infected cells, and
the mechanisms by which SARS-CoV-2 modulates the susceptibility of infected cells to NK cell cytotoxicity.
Thoroughly interrogating the responses of NK cells to SARS-CoV-2 will help to determine whether the role of
NK cells in COVID-19 is protective or pathological and will further our collective understanding of NK cell
biology. Moreover, the identification of receptors involved in the modulation of NK cell activation will inform the
development of therapeutic strategies for COVID-19.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Madeline Jane Lee其他文献
Madeline Jane Lee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Madeline Jane Lee', 18)}}的其他基金
Defining the role of natural killer cells in COVID-19
定义自然杀伤细胞在 COVID-19 中的作用
- 批准号:
10756069 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant